[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634487":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":25,"responsibleParty":36,"collaborators":10,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":10,"eligibilityCriteria":45,"healthyVolunteers":46,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":53,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":60,"overallStatus":65,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Gazi University","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Parkinson's Disease Group",null,"This group consists of individuals diagnosed with idiopathic Parkinson's Disease by a specialist neurologist according to the United Kingdom Parkinson's Disease Society Brain Bank clinical diagnostic criteria, with a disease severity between stages 1 and 3 according to the Modified Hoehn and Yahr Scale.",{"label":13,"type":10,"description":14,"interventionNames":10},"Healthy Control Group","This group includes healthy volunteers with similar age, gender, and educational background to the Parkinson's Disease group, and who have no history of any neurological, psychiatric, or musculoskeletal disorders that could affect gait or cognitive performance.",[16],{"name":17,"affiliation":5,"role":18},"Arzu GUCLU GUNDUZ","PRINCIPAL_INVESTIGATOR",[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Nisa Ceren YAVUZ","CONTACT","+90533 079 54 82","ynisaceren@gmail.com",[26],{"facility":27,"status":10,"city":28,"state":10,"zip":10,"country":29,"countryCode":10,"cosmosGeoPoint":30,"geoPoint":35,"contacts":10},"Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation.","Ankara","Turkey (Türkiye)",{"type":31,"coordinates":32},"Point",[33,34],32.85427,39.91987,{"lat":34,"lon":33},{"type":18,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Arzu Güçlü Gündüz","Profesor Doctor","100634487","effects-of-cognitive-dual-task-on-gait-in-parkinsons-disease-100634487",false,"NCT07540325","Effects of Cognitive Dual-Task on Gait in Parkinson's Disease","Investigating the Effects of Cognitive Dual-Task on Gait in Individuals With Parkinson's Disease","Inclusion Criteria for Individuals with Parkinson's Disease:\n\n* A clinical diagnosis of Parkinson's Disease confirmed by a neurologist according to the United Kingdom Parkinson's Disease Society Brain Bank diagnostic criteria\n* Classified between stages 1 and 3 according to the Modified Hoehn and Yahr Staging Scale\n* Aged between 40 and 80 years\n* A score of at least 21 on the Montreal Cognitive Assessment (MoCA)\n* Ability to walk continuously for at least 10 minutes without interruption and without the use of any assistive walking device\n* Having received at least 5 years of formal education\n\nExclusion Criteria for Individuals with Parkinson's Disease:\n\n* Presence of any neurological disorder other than Parkinson's Disease\n* Presence of any cardiopulmonary or musculoskeletal condition that may impair safe ambulation\n* A score of ≥10 for anxiety and ≥7 for depression on the Hospital Anxiety and Depression Scale (HADS)\n* Presence of visual or auditory impairments that cannot be corrected with assistive devices\n\nInclusion Criteria for Healthy Individuals:\n\n* Aged between 40 and 80 years\n* A score of at least 21 on the Montreal Cognitive Assessment (MoCA)\n\nExclusion Criteria for Healthy Individuals:\n\n* Presence of any neurological disorder\n* Presence of any cardiopulmonary or musculoskeletal condition that may affect safe ambulation\n* A score of ≥10 for anxiety and ≥7 for depression on the Hospital Anxiety and Depression Scale (HADS)\n* Presence of visual or auditory impairments that cannot be corrected with assistive devices",true,"ALL","40 Years","80 Years",{"count":51,"type":52},30,"ESTIMATED","2 Days","OBSERVATIONAL","The aim of this study is to evaluate gait in individuals diagnosed with PD under tasks involving different cognitive domains, to compare the results with those of age and sex-matched healthy individuals, and to determine which cognitive function has the greatest impact on gait in PD.",[57,58,59],"Parkinson's Disease (PD)","Cognition","Gait Disorders",[61,62,63,64],"Gait","Cognitive Function","Dual-Task","Parkinson's Disease","NOT_YET_RECRUITING","2026-04-17",{"date":68,"type":69},"2026-04-20","ACTUAL",{"date":68,"type":52},{"date":72,"type":52},"2026-12-31",{"name":5,"class":6},1]